hydrazine has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arumugaswamy, A; Brotchie, J; Grigg, A; He, S; Quach, H | 1 |
| Al-Banwan, K; Al-Jafar, HA; Al-Khaldi, J; Alduaij, A | 1 |
| Avorn, J; Franklin, JM; Kesselheim, AS; Landon, JE; Sarpatwari, A; Seeger, JD | 1 |
| Arnason, JE; Bussel, JB; Levy, B | 1 |
| Godeau, B | 1 |
| Dusheiko, G | 1 |
| Afdhal, NH; Berg, T; Blackman, N; Bourliere, M; Campbell, FM; Dusheiko, G; Gordon, SC; Jenkins, J; McHutchison, JG; Rodriguez-Torres, M; Shiffman, ML; Sigal, S; Theodore, D | 1 |
| Schwartz, RS | 1 |
| Lawson, A | 1 |
2 review(s) available for hydrazine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia.
Topics: Benzoates; Blood Platelets; Carrier Proteins; Chronic Disease; Clinical Trials as Topic; Hemorrhage; Hepatitis C; Humans; Hydrazines; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombocytopenia; Thrombopoiesis; Thrombopoietin; Treatment Outcome | 2008 |
Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C.
Topics: Benzoates; Bone Marrow; Carrier Proteins; Hematologic Agents; Hepatitis C; Humans; Hydrazines; Liver Cirrhosis; Liver Diseases; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombocytopenia; Thrombopoietin | 2009 |
1 trial(s) available for hydrazine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Benzoates; Double-Blind Method; Female; Headache; Hepatitis C; Humans; Hydrazines; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Pyrazoles; Receptors, Thrombopoietin; Recombinant Proteins; Thrombocytopenia | 2007 |
7 other study(ies) available for hydrazine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration.
Topics: Aged; Benzoates; Drug Evaluation; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Hydrazines; Immunosuppressive Agents; Male; Middle Aged; Platelet Count; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thrombopoietin; Time Factors | 2014 |
Severe thrombocytopenia in a patient with hepatitis C treated with eltrombopag from off-label drug use to on-label drug use: a case report.
Topics: Benzoates; Female; Hepatitis C; Humans; Hydrazines; Middle Aged; Off-Label Use; Pyrazoles; Severity of Illness Index; Thrombocytopenia; Treatment Outcome | 2014 |
Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopenia.
Topics: Adolescent; Adult; Aged; Benzoates; Female; Hepatitis C; Humans; Hydrazines; Male; Middle Aged; Off-Label Use; Patient Safety; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Retrospective Studies; Risk Assessment; Risk Reduction Behavior; Thrombopoietin; United States; Young Adult | 2015 |
Eltrombopag (Revolade ) and thrombocytopenia in patients with hepatitis C. Hepatotoxic drug; more harms than benefits.
Topics: Antiviral Agents; Benzoates; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Hepatitis C; Humans; Hydrazines; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia | 2015 |
[Thrombopoietin-receptor agonists: a revolution in the therapeutic strategies of immune thrombocytopenic purpura?].
Topics: Administration, Oral; Adult; Antiviral Agents; Benzoates; Carrier Proteins; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Female; Hepatitis C; Humans; Hydrazines; Immunoglobulins, Intravenous; Injections, Subcutaneous; Interferons; Myelodysplastic Syndromes; Placebos; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Ribavirin; Splenectomy; Thrombocytopenia; Thrombopoietin; Time Factors | 2009 |
Immune thrombocytopenic purpura--from agony to agonist.
Topics: Benzoates; Hepatitis C; History, 20th Century; Humans; Hydrazines; Liver Cirrhosis; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia | 2007 |
Eltrombopag in thrombocytopenia.
Topics: Benzoates; Hepatitis C; Humans; Hydrazines; Interferon alpha-2; Interferon-alpha; Interferons; Liver Cirrhosis; Platelet Count; Polyethylene Glycols; Pyrazoles; Receptors, Thrombopoietin; Recombinant Proteins; Thrombocytopenia | 2008 |